Transcriptic (now part of Strateos) was a pioneering biotechnology company, founded in 2012, that developed and operated a robotic cloud laboratory. This innovative platform allowed scientists worldwide to design and execute wet lab experiments remotely through a web interface. By automating complex biological and chemical assays, Transcriptic aimed to make research more efficient, reproducible, scalable, and accessible, particularly for drug discovery and basic life science research. The company was acquired by Strateos in May 2019, combining its capabilities with 3Scan's imaging technology to form a more comprehensive automated discovery platform.
Served as the central R&D hub, software development center, and operational site for its robotic cloud laboratory, managing and executing automated experiments for a global client base.
A pioneering, large-scale robotic cloud laboratory equipped with custom automation systems for diverse molecular and cell biology assays, all accessible and controllable via a sophisticated web interface.
Transcriptic fostered an innovative, agile, and mission-driven work environment. It encouraged interdisciplinary collaboration between biologists, engineers, and software developers, all focused on revolutionizing scientific experimentation through automation and remote access.
The Menlo Park facility was highly significant as it housed one of the first commercially successful robotic cloud laboratories. It demonstrated the viability of lab automation-as-a-service, making sophisticated research tools accessible to smaller labs, startups, and individual researchers, thereby advancing the reproducibility and speed of scientific discovery.
While physically based in its Menlo Park, California facility, Transcriptic offered its services to a global clientele. Scientists and research organizations from around the world could remotely access its automated laboratory platform via the internet to design, run, and monitor experiments. This web-based model effectively gave Transcriptic a global reach, enabling researchers anywhere to utilize its advanced automation capabilities without needing physical access to the lab equipment.
270 Constitution Dr
Menlo Park
CA
USA
Address: N/A
N/A
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Transcriptic' leadership includes:
Transcriptic has been backed by several prominent investors over the years, including:
Transcriptic was acquired by Strateos in May 2019 and ceased to operate as an independent entity. Consequently, there have been no executive hires or exits directly attributed to 'Transcriptic' in the last 12 months. Key executive transitions occurred at the time of the merger. For current executive team information and recent changes, please refer to Strateos.
Discover the tools Transcriptic uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Historically, while Transcriptic was operational, common corporate email formats were likely in use, such as [first_initial][last]@transcriptic.com or [first].[last]@transcriptic.com. Since the acquisition by Strateos and the phasing out of the transcriptic.com domain for active email communications, the deliverability success rate for these historical formats is now 0%. For current contact, refer to Strateos' communication channels.
[first_initial][last]@transcriptic.com (historical)
Format
jdoe@transcriptic.com (historical example)
Example
0%
Success rate
PR Newswire • May 16, 2019
Strateos (formerly 3Scan) announced its acquisition of Transcriptic, uniting 3Scan's 3D spatial biology imaging with Transcriptic's renowned robotic cloud lab capabilities. This merger aimed to create a comprehensive, on-demand automation platform to accelerate life science research and drug discovery....more
TechCrunch • November 30, 2017
Transcriptic secured $13.4 million in a Series A-II funding round. The investment, involving Data Collective (DCVC), IA Ventures, AME Cloud Ventures, and others, was aimed at expanding its automated experimental services and further developing its platform for drug discovery and biological research....more
VentureBeat • January 29, 2015
Transcriptic announced it had raised $8.5 million in Series A funding. The round was led by IA Ventures and Data Collective, with participation from AME Cloud Ventures and Founders Fund, to further its mission of making laboratory work faster, cheaper, and more reproducible through its remote robotic lab services....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Transcriptic, are just a search away.